Abstract
A fine homeostasis of the brain extracellular fluid is required for the neural cells to fulfill their complex physiological fonctions. This homeostasis is achieved and controlled by several mechanisms which primarily involve the specific features of the blood-brain interfaces (BBI). These interfaces include the cerebral capillaries forming the blood-brain barrier (BBB), and the choroid plexuses. The latter are located in the lateral, third and fourth ventricles and, together with the meningeal arachnoid, control the exchange processes between the blood and the cerebrospinal fluid (CSF). In addition, the continuous secretion, circulation and resorption of CSF, a circulatory system which is specific to the central nervous system, also participates in the maintenance of cerebral homeostasis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fenstermacher, J.D., Bereczki, D., Wei, L., Chen, J.L., Hans, F.J., Acuff, V., and Patlak, C.S., 1993, The pharmacology of the blood-brain barrier and cerebral extracellular fluid, in CNS Barriers and Modern CSF Diagnostics (K. Felgenhauer, M. Holzgraefe, and H.W. Prange, eds.), VCH Verlags, Weinheim, New York, pp.31–40.
Ghersi-Egea, J.F., Minn, A., and Siest, G., 1988, A new aspect of the protective functions of the blood-brain barrier: activities of four drug metabolizing enzymes in isolated microvessels. Life Sci 42: 2515–2523.
Ghersi-Egea J.F. and Livertoux M.H., 1992, Evidence for drug metabolism as a source of reactive species in the brain. In Free Radicals and Aging, Emerit I. and Chance B. eds., Birkhauser Verlag, Basel, pp 218–226.
Ghersi-Egea, J.F., Leininger-Muller, B., Suleman, G., Siest, G. and Minn, A., 1994, Localization of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs. J. Neurochem. 62: 1089–1096.
Ghersi-Egea, J.F., Finnegan, W., Chen, J.L., and Fenstermacher, J.D., 1996, Rapid distribution of intraventricularly administered sucrose into cerebrospinal fluid cisterns via subarachnoid velae in rat. Neuroscience, 75: 1271–1288.
Ghersi-Egea J.F., Maupoil V., Ray D. and Rochette L., 1998, Electronic spin resonance detection of Superoxide and hydroxyl radicals during the reductive metabolism of drugs by rat brain preparations and isolated cerebral microvessels. Free Rad. Biol. Med., 24, 1074–1081.
Ghersi-Egea, J.F. and Strazielle, N., 2001, Brain drug delivery, drug metabolism and multidrug resistance at the choroid plexus. Microscopy Research and Technique, 52: in press.
Monks, T.J., Ghersi-Egea, J.F., Philbert, M., Cooper, A.J., and Lock, E.A., 1999, the role of glutathione in neuroprotection and neurotoxicity. Toxicol. Sci., 51: 161–177.
Nishino, J., Suzuki, H., Sugiyama, D., Kitazawa, T., Ito, K., Hanano, M., and Sugiyama, Y., 1999, Transepithelial transport of organic anions across the choroid plexus: possible involvement of organic anion transporter and multidrug resistance-associated protein. J. Pharmacol. Exp. Ther., 290: 289–294.
Rao, V.V., Dahlheimer, J.L., Bardgett, M.E., Snyder, A.Z., Finch, R.A., Sartorelli, A.C., and Piwnica-Worms, D., 1999, Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proc. Natl. Acad. Sci. U S A, 96: 3900–3905.
Schinkel, A.H., Wagenaar, E., Mol, CA., and van Deemter, L., 1996, P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J. Clin. Invest., 97: 2517–2524.
Strazielle, N., and Ghersi-Egea, J.F., 1999, Demonstration of a coupled metabolism-efflux process at the choroid plexus as a mechanism of brain protection toward xenobiotics. J. Neurosci., 19: 6275–6289.
Strazielle, N., and Ghersi-Egea, J.F., 2000a, Choroid plexus in the central nervous system: biology and physiopathology. J. Neuropathol. Exp. Neurol., 59: 561–574.
Strazielle, N., and Ghersi-Egea, J.F., 2000b, Implication of blood-brain interfaces in cerebral drug metabolism and drug metabolite disposition. In: Molecular drug metabolism and toxicology, chap. 12 (G. M. Williams, and O.I. Aruoma, eds.), OICA International, London, pp 181–200.
Suzuki, H., Terasaki, T., and Sugiyama, Y., 1997, Role of efflux transport across the bloodbrain and blood-cerebrospinal fluid barrier on the disposition of xenobiotics in the central nervous system, Adv. Drug Deliv. Rev., 25: 257–285.
Tarayani I, Cloez I., Clement M. and Bourre J.M., 1989, Antioxidant enzymes and related trace elements in aging brain capillaries and choroid plexus. J. Neurochem. 53 817–824.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ghersi-Egea, JF., Strazielle, N., Belin, MF. (2001). Neuroprotective and Detoxifying Mechanisms at the Blood-Brain Interfaces. In: Kobiler, D., Lustig, S., Shapira, S. (eds) Blood—Brain Barrier. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0579-2_3
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0579-2_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5141-2
Online ISBN: 978-1-4615-0579-2
eBook Packages: Springer Book Archive